Biopharmaceutical company
Appears in 1 story · Last updated Oct 19, 2026
FDA approved Furoscix ReadyFlow in July 2026
A randomized trial published October 14 in the Journal of the American College of Cardiology found that heart failure patients sent home with a wearable diuretic pump gained four days alive and out of hospital over the next month, versus usual inpatient care. Real-world results presented three days earlier at a Heart Failure Society of America meeting showed 86% of at-risk patients treated at home cleared their congestion without being admitted.
Updated Oct 18
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
